Onconetix Inc.宣布子公司Proteomedix向Immunovia授权制造知识产权,助力后者独立生产胰腺癌检测试剂

美股速递
Sep 22

Onconetix Inc.日前宣布,其子公司Proteomedix已向Immunovia授权相关制造知识产权,此举将使Immunovia能够独立生产其胰腺癌检测产品PancreasureTM所需的关键试剂。

通过这项授权协议,Immunovia将获得必要的技术支持,提升其在胰腺癌早期检测领域的自主生产能力,进一步巩固其在精准医疗诊断市场的地位。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10